Glaukos Corporation

Glaukos Corporation is a pioneering medical technology company dedicated to transforming the treatment of glaucoma and other eye diseases. Founded in 1998, the company has established itself as a leader in the development of innovative surgical solutions that aim to improve patient outcomes and enhance the quality of life for those affected by vision impairment.

At the core of Glaukos’ mission is the commitment to advancing the field of ophthalmology through cutting-edge research and development. The company’s flagship product, the iStent, is the first micro-invasive glaucoma surgery device approved by the FDA, which has revolutionised the way glaucoma is treated.

Glaukos operates with a strong focus on innovation, investing significantly in clinical trials and studies to ensure the efficacy and safety of its products. The company collaborates with leading ophthalmologists and researchers worldwide to stay at the forefront of technological advancements in eye care.

In addition to its groundbreaking products, Glaukos is dedicated to educating healthcare professionals and patients about glaucoma management and treatment options. The company believes that informed patients are empowered to make better decisions regarding their health.

With headquarters located in the United States, Glaukos is expanding its reach globally, including efforts to establish a presence in the UK market. The company aims to provide access to its innovative solutions to patients and healthcare providers across Europe.

Glaukos Corporation is not just a business; it is a community of passionate individuals committed to making a difference in the lives of those suffering from eye diseases. The company’s vision is to be the global leader in the development of transformative therapies for glaucoma and other ocular conditions.

• Founded: 1998
• Headquarters: United States
• Core Focus: Innovative surgical solutions for glaucoma
• Flagship Product: iStent
• Global Expansion: Efforts to enter the UK market